Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)
Clinical trial NCT05314023 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05314023
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-07
- Primary completion
- 2029-02-19
- Enrollment
- 1590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.